BONANNO, LAURA

BONANNO, LAURA  

Dipartimento di Scienze Chirurgiche Oncologiche e Gastroenterologiche - DiSCOG  

Mostra records
Risultati 1 - 20 di 114 (tempo di esecuzione: 0.075 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
MAPK pathway activating alteration and immunotherapy efficacy in squamous cell lung carcinoma: results from the randomized, prospective SQUINT trial 2025 Bonanno, LauraDal Maso, Alessandro + CLINICAL CANCER RESEARCH - -
Molecular residual disease analysis of adjuvant osimertinib in resected EGFR-mutated stage IB–IIIA non-small-cell lung cancer 2025 Bonanno, Laura + NATURE MEDICINE - -
Perioperative Chemo-Immunotherapy in Non-Oncogene-Addicted Resectable Non-Small Cell Lung Cancer (NSCLC): Italian Expert Panel Meeting 2025 Bonanno, LauraRea, Federico + CURRENT ONCOLOGY - -
Binary classification of copy number alteration profiles in liquid biopsy with potential clinical impact in advanced NSCLC 2024 Zulato, ElisabettaPasello, GiuliaGuarneri, ValentinaIndraccolo, StefanoBonanno, Laura + SCIENTIFIC REPORTS - -
Clinical applications of radiomics and deep learning in breast and lung cancer: A narrative literature review on current evidence and future perspectives 2024 Bottosso, MicheleDieci, Maria VittoriaMiglietta, FedericaBonanno, LauraGuarneri, ValentinaGriguolo, GaiaPasello, Giulia + CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY - -
Clinical evidence and adverse event management update of patients with RET- rearranged advanced non-small-cell lung cancer (NSCLC) treated with pralsetinib 2024 Bonanno, Laura + CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY - -
Efficacy of osimertinib and the role of sequential liquid biopsy in patients diagnosed with NSCLC harboring EGFR and BRAF mutations at baseline: insights from two case reports 2024 Boscolo Bragadin, AndreaGuarneri, ValentinaBonanno, LauraIndraccolo, Stefano + FRONTIERS IN ONCOLOGY - -
Extensive-stage small-cell lung cancer in patients receiving atezolizumab plus carboplatin-etoposide: stratification of outcome based on a composite score that combines gene expression profiling and immune characterization of microenvironment 2024 Tosi, AnnaPavan, AlbertoBonanno, LauraCalabrese, FiorellaGuarneri, ValentinaRosato, AntonioPasello, Giulia + JOURNAL FOR IMMUNOTHERAPY OF CANCER - -
Immune-related adverse events in patients treated with immunotherapy for locally advanced or metastatic NSCLC in real-world settings: a systematic review and meta-analysis 2024 Pasello, GiuliaPavan, AlbertoDal Maso, AlessandroBonanno, LauraGuarneri, Valentina + FRONTIERS IN ONCOLOGY - -
Immune-Related Diarrhea and Colitis in Non-small Cell Lung Cancers: Impact of Multidisciplinary Management in a Real-World Setting 2024 Bonanno, LauraZingone, FabianaBarberio, BrigidaDal Maso, AlessandroPasello, GiuliaDei Tos, Angelo PaoloFassan, MatteoSavarino, Edoardo VincenzoGuarneri, Valentina + THE ONCOLOGIST - -
Immunotherapy in Non-Small-Cell Lung Cancer: A Modified Delphi Survey Consensus on First Line Treatment, Special Populations and Rechallenge 2024 Bonanno, Laura + BIOMEDICINES - -
Longitudinal liquid biopsy predicts clinical benefit from immunotherapy in advanced non-small cell lung cancer 2024 Boscolo Bragadin, AndreaZulato, ElisabettaPavan, AlbertoGuarneri, ValentinaIndraccolo, StefanoBonanno, Laura + NPJ PRECISION ONCOLOGY - -
NGS detection of gene rearrangements and METexon14 mutations in liquid biopsy of advanced NSCLC patients: A study of two Italian centers 2024 Andrea Boscolo BragadinGiulia PaselloElisabetta ZulatoLaura BonannoStefano Indraccolo + THE JOURNAL OF LIQUID BIOPSY - -
Osimertinib in Patients With Treatment-Naive EGFR-Mutant Non-small Cell Lung Cancer: Overall Survival, Post-progression Management and Budget Impact Analysis in Real-World 2024 Pasello, GiuliaPavan, AlbertoPolo, ValentinaBonanno, LauraDal Maso, AlessandroGuarneri, Valentina + THE ONCOLOGIST - -
Real-world impact of the introduction of chemo-immunotherapy in extended small cell lung cancer: a multicentric analysis 2024 Bonanno, LauraDal Maso, AlessandroPavan, AlbertoPasello, GiuliaGuarneri, Valentina + FRONTIERS IN IMMUNOLOGY - -
Sex-related differences in serum biomarker levels predict the activity and efficacy of immune checkpoint inhibitors in advanced melanoma and non-small cell lung cancer patients 2024 Pasello, GiuliaSalizzato, ValentinaPiccin, LuisaBonanno, LauraGuarneri, Valentina + JOURNAL OF TRANSLATIONAL MEDICINE - -
Summary of Research: Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC 2024 Bonanno, Laura + TARGETED ONCOLOGY - -
The emerging role of Schlafen-11 (SLFN11) in predicting response to anticancer treatments: Focus on small cell lung cancer 2024 Maso, Alessandro DalBonanno, LauraGuarneri, ValentinaPasello, Giulia + CANCER TREATMENT REVIEWS - -
The study of primary and acquired resistance to first-line osimertinib to improve the outcome of EGFR-mutated advanced Non-small cell lung cancer patients: the challenge is open for new therapeutic strategies 2024 Marinato, Gian MarcoPasello, GiuliaGuarneri, ValentinaBonanno, Laura + CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY - -
Tissue and circulating biomarkers of benefit to immunotherapy in extensive-stage small cell lung cancer patients 2024 Bonanno, LauraDal Maso, AlessandroGuarneri, ValentinaPasello, Giulia + FRONTIERS IN IMMUNOLOGY - -